|
Volumn 11, Issue 12, 2003, Pages 785-789
|
Antiemetic prescription in Italian breast cancer patients submitted to adjuvant chemotherapy
|
Author keywords
Antiemetics; Drug utilization study; Guidelines; Prescriptive appropriateness
|
Indexed keywords
ANTHRACYCLINE DERIVATIVE;
ANTIEMETIC AGENT;
ANTINEOPLASTIC AGENT;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
METHOTREXATE;
METOCLOPRAMIDE;
SEROTONIN 3 ANTAGONIST;
TAXANE DERIVATIVE;
ARTICLE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CHEMOTHERAPY INDUCED EMESIS;
CLINICAL PRACTICE;
CLINICAL PROTOCOL;
CONTROLLED STUDY;
DRUG UTILIZATION;
HEALTH CARE ORGANIZATION;
HUMAN;
ITALY;
MAJOR CLINICAL STUDY;
PATIENT CARE;
PATIENT MONITORING;
PRACTICE GUIDELINE;
PRESCRIPTION;
PRIORITY JOURNAL;
PUBLICATION;
ANTIEMETICS;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
FEMALE;
GUIDELINE ADHERENCE;
HUMANS;
INFORMATION DISSEMINATION;
ITALY;
PRACTICE GUIDELINES;
SOCIAL SUPPORT;
VOMITING;
|
EID: 0346993723
PISSN: 09414355
EISSN: None
Source Type: Journal
DOI: 10.1007/s00520-003-0478-0 Document Type: Article |
Times cited : (16)
|
References (5)
|